Drug Profile
Research programme: antibacterials - Oragenics
Alternative Names: Lantibiotics; MU 1140-S; MU-1140; MU1140 analogs - Oragenics; Mutacin 1140; OG 253; OG 716Latest Information Update: 15 Apr 2024
Price :
$50
*
At a glance
- Originator Texas A&M University; University of Florida
- Developer Oragenics Inc
- Class Antibacterials; Bacteriocins; Cyclic peptides
- Mechanism of Action Cell membrane permeability enhancers; Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Clostridium difficile infections